- Home
- SHC vs RARE Comparison
SHC vs RARE Comparison
Compare SHC & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHC
- RARE
- Stock Information
- Founded
- SHC 2015
- RARE 2010
- Country
- SHC United States
- RARE United States
- Employees
- SHC N/A
- RARE N/A
- Industry
- SHC Medical Specialities
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- SHC Health Care
- RARE Health Care
- Exchange
- SHC Nasdaq
- RARE Nasdaq
- Market Cap
- SHC 3.2B
- RARE 3.5B
- IPO Year
- SHC 2020
- RARE 2014
- Fundamental
- Price
- SHC $11.64
- RARE $29.23
- Analyst Decision
- SHC Strong Buy
- RARE Strong Buy
- Analyst Count
- SHC 5
- RARE 15
- Target Price
- SHC $16.00
- RARE $87.40
- AVG Volume (30 Days)
- SHC 1.2M
- RARE 2.0M
- Earning Date
- SHC 08-04-2025
- RARE 07-31-2025
- Dividend Yield
- SHC N/A
- RARE N/A
- EPS Growth
- SHC N/A
- RARE N/A
- EPS
- SHC 0.09
- RARE N/A
- Revenue
- SHC $1,106,788,000.00
- RARE $590,689,000.00
- Revenue This Year
- SHC $4.78
- RARE $18.94
- Revenue Next Year
- SHC $5.90
- RARE $28.61
- P/E Ratio
- SHC $132.81
- RARE N/A
- Revenue Growth
- SHC 2.78
- RARE 33.46
- 52 Week Low
- SHC $9.53
- RARE $28.35
- 52 Week High
- SHC $17.08
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- SHC 51.71
- RARE 30.28
- Support Level
- SHC $11.36
- RARE $38.91
- Resistance Level
- SHC $12.13
- RARE $42.37
- Average True Range (ATR)
- SHC 0.33
- RARE 1.87
- MACD
- SHC 0.08
- RARE -0.99
- Stochastic Oscillator
- SHC 67.92
- RARE 6.28
About SHC Sotera Health Company
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.